Cargando…
Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one
Statins are promising anticancer agents that target the mevalonate pathway. Tumor cells are sensitive to depletion of mevalonate-derived products but this activity triggers a homeostatic feedback loop that blunts statin efficacy. We showed that dipyridamole inhibits this feedback response and potent...
Autores principales: | Pandyra, Aleksandra, Penn, Linda Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905210/ https://www.ncbi.nlm.nih.gov/pubmed/27308369 http://dx.doi.org/10.4161/23723548.2014.969133 |
Ejemplares similares
-
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death
por: Pandyra, Aleksandra A., et al.
Publicado: (2015) -
Whether two heads are better than one is the wrong question (though sometimes they are)
por: Hautz, Wolf E., et al.
Publicado: (2020) -
Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin
por: Zhao, Jing, et al.
Publicado: (2014) -
Is Two Better Than One? Anticipation of a Favorable Hemodynamic Profile by Combining the Hypnotic Drugs for Induction of Anesthesia
por: Nader, Nader D.
Publicado: (2015) -
Is one better than two?
por: Kim, Tae-Il
Publicado: (2013)